Nvidia, AMD to pay 15% of China chip sales revenue to US govt- FT
NanoViricides Inc (NNVC) stock has reached a new 52-week low, dipping to $1.02, as the company faces ongoing market headwinds. With a beta of 1.14, the stock shows higher volatility than the broader market. Despite challenges, the company maintains a healthy current ratio of 3.44, indicating strong short-term liquidity. This latest price level reflects a significant downturn, with the stock down 20.28% year-to-date. Investors are closely monitoring the biopharmaceutical company, known for its work in developing nanomedicine technologies to combat viral infections, as it navigates through a challenging period. InvestingPro analysis reveals concerning trends, including weak gross profit margins and profitability challenges. Additional insights and detailed financial metrics are available through InvestingPro’s comprehensive analysis tools.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.